- Price
- $971.31
- Day
- +3.12%
- Mkt Cap
- $258.69B
- 52W Range
- $530.16 – $1,195.94
- Volume
- 1.69M
- Beta
- 0.97
Find a company by name or ticker and open its page
Snapshot of fundamentals, performance, and 5D scores.
Business fundamentals and company information
Recent price action and historical returns
How the business makes money, by product and geography
Five lenses on the stock. Click any card to dive deeper.
How to read these dimensions
The five dimensions are independent lenses on a company, not a single combined score. Read them together rather than in isolation: where one dimension scores differently from the others is often the most useful place to focus your own research. Each score is built from rules and weights you can adjust, so treat them as a transparent starting point for your analysis, not a recommendation to buy or sell.
Recent news headlines and analyst price-target moves
Allworth Financial LP Cuts Stock Position in GE Vernova Inc. $GEV
Allworth Financial LP decreased its holdings in shares of GE Vernova Inc. (NYSE: GEV) by 38.1% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,110 shares of the company's stock after selling 6,228 shares during the quarter. Allworth Financial LP's
3 Stocks Built for Higher Rates—And 2 That Could Break
The August jobs report landed Friday morning with 162,000 new positions against forecasts of 56,000, and the bond market read it as a reason to keep bracing. The 10-year Treasury yield pushed back toward 4.79%, near its highest level since late 2023, and a hike at the Fed's Sept.
Construction Firms Powering the Nuclear Renaissance
Investors usually focus on reactor developers and uranium miners when deciding on allocations for investing in the nuclear renaissance. A narrow view on the nuclear sector could result in missed opportunities for investment returns in nuclear-adjacent companies.
Sam Altman's AI Usage Prediction Is Wild — But These 3 Stocks Could Cash In
Artificial intelligence is moving from an interesting software feature into something closer to a new industrial utility. The numbers behind that transition are getting difficult to ignore.
Jim Cramer: This Health Care Stock Is Pure Spec, The Only Neocloud I Like Is
On CNBC's “Mad Money Lightning Round,” Jim Cramer said Nuvation Bio Inc. (NYSE:NUVB) is a “pure spec.”